Trends in survival of multiple myeloma: a thirty-year population-based study in a single institution.

  title={Trends in survival of multiple myeloma: a thirty-year population-based study in a single institution.},
  author={R R{\'i}os-Tamayo and Mar{\'i}a Jos{\'e} S{\'a}nchez and Jos{\'e} Manuel Puerta and Juan Sainz and Daysi-Yoe-Ling Chang and Teresa Rodr{\'i}guez and Pilar Castro L{\'o}pez and Jos{\'e} Mar{\'i}a de Pablos and Pilar Navarro and Jos{\'e} Lu{\'i}s Garc{\'i}a de Veas and Antonio Romero and Pilar Garrido and Luc{\'i}a Moratalla and Carolina Alarc{\'o}n-Payer and Elisa L{\'o}pez-Fern{\'a}ndez and Pedro Antonio D{\'a}valos Gonz{\'a}lez and Jos{\'e} Juan Jim{\'e}nez-Mole{\'o}n and Miguel Angel Calleja-Hern{\'a}ndez and Manuel Jurado},
  journal={Cancer epidemiology},
  volume={39 5},
  • R Ríos-Tamayo, María José Sánchez, +16 authors Manuel Jurado
  • Published in Cancer epidemiology 2015
  • Medicine
  • BACKGROUND Despite the progress made in recent years, multiple myeloma is still considered an incurable disease. Most survival data come from clinical trials. Little is known about the outcome in unselected real-life patients. METHODS Overall survival was analyzed in a cohort of newly diagnosed symptomatic multiple myeloma patients, over the last three decades, in a single institution population-based study. RESULTS 582 consecutive myeloma patients were included in the study. Survival… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Twitter Mentions


    Publications citing this paper.